These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 35916346)

  • 21. Investigation of Potential Paraoxonase-I Inhibitors by Kinetic and Molecular Docking Studies: Chemotherapeutic Drugs.
    Türkeş C
    Protein Pept Lett; 2019; 26(6):392-402. PubMed ID: 30819074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Toward Understanding the Catalytic Mechanism of Human Paraoxonase 1: Site-Specific Mutagenesis at Position 192.
    Aggarwal G; Prajapati R; Tripathy RK; Bajaj P; Iyengar AR; Sangamwar AT; Pande AH
    PLoS One; 2016; 11(2):e0147999. PubMed ID: 26829396
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential effects of selective serotonin reuptake inhibitors on paraoxonase-1 enzyme activity: An in vitro study.
    Demir Y; Balcı N; Gürbüz M
    Comp Biochem Physiol C Toxicol Pharmacol; 2019 Dec; 226():108608. PubMed ID: 31422163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paraoxonase-1 (PON1) Status Analysis Using Non-Organophosphate Substrates.
    Marsillach J; Richter RJ; Costa LG; Furlong CE
    Curr Protoc; 2021 Jan; 1(1):e25. PubMed ID: 33484495
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Korkmaz IN; Güller P; Kalın R; Öztekin A; Özdemir H
    Curr Comput Aided Drug Des; 2022; 18(5):381-392. PubMed ID: 35984020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paraoxonase (PON1) polymorphism and activity as the determinants of sensitivity to organophosphates in human subjects.
    Sirivarasai J; Kaojarern S; Yoovathaworn K; Sura T
    Chem Biol Interact; 2007 Jul; 168(3):184-92. PubMed ID: 17532308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibiotics Used in Patients after Surgery and Effects of Human Serum Paraoxonase-I (PON1) Enzyme Activity.
    Yılmaz A; Dilek E
    Protein Pept Lett; 2019; 26(3):215-220. PubMed ID: 30678610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of paraoxonase (PON1) in the detoxication of organophosphates and its human polymorphism.
    Costa LG; Li WF; Richter RJ; Shih DM; Lusis A; Furlong CE
    Chem Biol Interact; 1999 May; 119-120():429-38. PubMed ID: 10421480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Some cardiovascular therapeutics inhibit paraoxonase 1 (PON1) from human serum.
    Işgör MM; Beydemir S
    Eur J Pharmacol; 2010 Oct; 645(1-3):135-42. PubMed ID: 20670621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A potential risk factor for paraoxonase 1: in silico and in-vitro analysis of the biological activity of proton-pump inhibitors.
    Türkeş C
    J Pharm Pharmacol; 2019 Oct; 71(10):1553-1564. PubMed ID: 31353473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New chemiluminescent substrates of paraoxonase 1 with improved specificity: synthesis and properties.
    Abulimite Z; Mu X; Xiao S; Liu M; Li Q; Chen G
    Appl Biochem Biotechnol; 2015 May; 176(1):301-16. PubMed ID: 25809994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of paraoxonase 1 192 Q/R polymorphism on paraoxonase and acetylcholinesterase enzyme activities in a Turkish population exposed to organophosphate.
    Sunay SZ; Kayaaltı Z; Bayrak T; Söylemezoğlu T
    Toxicol Ind Health; 2015 Dec; 31(12):1061-8. PubMed ID: 23625910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and in vitro urease inhibitory activity of benzohydrazide derivatives, in silico and kinetic studies.
    Abbas A; Ali B; Kanwal ; Khan KM; Iqbal J; Ur Rahman S; Zaib S; Perveen S
    Bioorg Chem; 2019 Feb; 82():163-177. PubMed ID: 30321779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro efficacy of some cattle drugs on bovine serum paraoxonase 1 (PON1) activity.
    Arslan M; Gencer N; Arslan O; Guler OO
    J Enzyme Inhib Med Chem; 2012 Oct; 27(5):722-9. PubMed ID: 21985443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antidepressant and antipsychotic drugs differentially affect PON1 enzyme activity.
    Avcikurt AS; Sinan S; Kockar F
    J Enzyme Inhib Med Chem; 2015 Apr; 30(2):245-9. PubMed ID: 24934243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of some antibiotics on paraoxonase from human serum in vitro and from mouse serum and liver in vivo.
    Sinan S; Kockar F; Gencer N; Yildirim H; Arslan O
    Biol Pharm Bull; 2006 Aug; 29(8):1559-63. PubMed ID: 16880604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure-reactivity studies of serum paraoxonase PON1 suggest that its native activity is lactonase.
    Khersonsky O; Tawfik DS
    Biochemistry; 2005 Apr; 44(16):6371-82. PubMed ID: 15835926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tandem purification of two HDL-associated partner proteins in human plasma, paraoxonase (PON1) and phosphate binding protein (HPBP) using hydroxyapatite chromatography.
    Renault F; Chabrière E; Andrieu JP; Dublet B; Masson P; Rochu D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 May; 836(1-2):15-21. PubMed ID: 16595195
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel nucleophiles enhance the human serum paraoxonase 1 (PON1)-mediated detoxication of organophosphates.
    Chambers JE; Chambers HW; Meek EC; Funck KE; Bhavaraju MH; Gwaltney SR; Pringle RB
    Toxicol Sci; 2015 Jan; 143(1):46-53. PubMed ID: 25304213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Semicarbazone derivatives as urease inhibitors: Synthesis, biological evaluation, molecular docking studies and in-silico ADME evaluation.
    Qazi SU; Rahman SU; Awan AN; Al-Rashida M; Alharthy RD; Asari A; Hameed A; Iqbal J
    Bioorg Chem; 2018 Sep; 79():19-26. PubMed ID: 29709568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.